VL
CDMO

Vima LLC’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Vima LLC’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$4.67K – 405
2024
Q1 		$4.67K Sell
700
-163
-19% -$1.12K 0.01% 300
2023
Q4 		$6.83K Buy
+863
New +$5.56K 0.02% 272

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Vima LLC's CDMO Position: Q2 2024 in Review

Vima LLC sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2024, closing a stake of 700 shares — an estimated $4.67K sold.

Vima LLC first reported a position in CDMO in Q4 2023 and held it in 2 quarters. The position peaked at $6.83K in Q4 2023. 171 funds tracked by Wall St. Rank hold CDMO as of Q2 2024.

  • Vima LLC reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vima LLC sold 700 Avid Bioservices, Inc. Common Stock shares in Q2 2024, an estimated $4.67K.
  • Vima LLC first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Vima LLC's Avid Bioservices, Inc. Common Stock position peaked at $6.83K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2024.

Based on Vima LLC's 13F filing for Q2 2024, filed 8 Aug 2024.